The two New Jersey suits assert eight patents against Pfizer and 10 against Moderna, extending existing mRNA litigation ...

The answer would seem to put her in direct conflict with Health Secretary RFK Jr.

Ambient-stable microneedle patches are positioned as a route to reduce refrigeration dependence and simplify administration ...

As Pfizer and Moderna have tied off certain threads in their separate webs of mRNA patent litigation, Sanofi has opened a new ...

A new kind of flu vaccine is moving a step closer to the U.S. market.

Moderna gains fresh market attention after a unanimous flu vaccine panel vote strengthens confidence in its mRNA vaccine ...

All nine members of the committee unanimously voted to recommend Moderna's new mRNA influenza vaccine for adults 50 and over.

Moderna's mRNA flu vaccine could be approved by August, but federal policy and a nonfunctional advisory committee threaten ...

Messenger RNA (mRNA) vaccines are one of the biggest medical breakthroughs of recent years. It was first introduced during the Covid-19 pandemic and they helpe ...

MASSACHUSETTS - Advisers to the US Food and Drug Administration on June 18 backed approval of Moderna’s flu vaccine for adults aged 50 and older, saying its benefits outweigh the risks, boosting the ...

The mRNA vaccines approved to treat COVID-19 are safe and effective and show promise in treating other diseases including cancer, according to a new review published in The Lancet Tuesday.

The panel unanimously said that the benefits of Moderna's mRNA jab outweigh its risks in preventing influenza in certain age groups.